Who
Jeffrey Lawrence Schwartz
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Kestra Medical Technologies; Director and 10% owner, Rapid Micro Biosystems; Director and 10% owner, SpringWorks Therapeutics; Chief Executive Officer, BCLS Acquisition.
In numbers
- Trades disclosed
- 22
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $50.1M
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 29 Mar 2019
- Last trade
- 9 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Sep 2026filed 10 Sep 2026 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Code A | —7,217 | filing |
| 9 Sep 2026filed 10 Sep 2026 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Code A | —7,217 | filing |
| 8 Sep 2026filed 10 Sep 2026 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Sold | $98K3,890 at $25.18 | filing |
| 8 Sep 2026filed 10 Sep 2026 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Sold | $98K3,890 at $25.18 | filing |
| 4 Sep 2025filed 8 Sep 2025 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Code A | —10,909 | filing |
| 23 May 2024filed 28 May 2024 | RPID Rapid Micro Biosystemsoption or derivative · Life-science tools | SEC FORM 4 Code A | —28,650 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | RPID Rapid Micro BiosystemsLife-science tools | SEC FORM 4 Code A | —14,300 at $0.00 | filing |
| 24 May 2023filed 25 May 2023 | SpringWorks Therapeuticsoption or derivative | SEC FORM 4 Code A | —13,774 at $0.00 | filing |
| 24 May 2023filed 25 May 2023 | SpringWorks Therapeutics | SEC FORM 4 Code A | —4,648 at $0.00 | filing |
| 4 May 2023filed 5 May 2023 | RPID Rapid Micro Biosystemsoption or derivative · Life-science tools | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 16 Mar 2023filed 20 Mar 2023 | SpringWorks Therapeutics | SEC FORM 4 Sold | $49.9M1,750,000 at $28.50 | filing |
| 23 May 2022filed 10 Jun 2022 | RPID Rapid Micro Biosystemsoption or derivative · Life-science tools | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 19 May 2022filed 20 May 2022 | SpringWorks Therapeuticsoption or derivative | SEC FORM 4 Code A | —15,318 at $0.00 | filing |
| 19 May 2022filed 20 May 2022 | SpringWorks Therapeutics | SEC FORM 4 Code A | —4,818 at $0.00 | filing |
| 14 Jul 2021filed 16 Jul 2021 | RPID Rapid Micro Biosystemsoption or derivative · Life-science tools | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 20 May 2021filed 24 May 2021 | SpringWorks Therapeutics | SEC FORM 4 Code A | —1,106 at $0.00 | filing |
| 20 May 2021filed 24 May 2021 | SpringWorks Therapeuticsoption or derivative | SEC FORM 4 Code A | —6,998 at $0.00 | filing |
| 26 Oct 2020filed 26 Oct 2020 | BCLS Acquisition | SEC FORM 4 Code A | $4.9M487,500 at $10.00 | filing |
| 20 May 2020filed 22 May 2020 | SpringWorks Therapeuticsoption or derivative | SEC FORM 4 Code A | —7,464 at $0.00 | filing |
| 12 Sep 2019filed 16 Sep 2019 | SpringWorks Therapeuticsoption or derivative | SEC FORM 4 Code A | —29,983 at $0.00 | filing |
News
Insider Selling: Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells 15,000 Shares of Company StockKMTS · dailypolitical.com · 22 Oct 2026Evercore Begins Coverage on Kestra Medical Technologies (NASDAQ:KMTS)KMTS · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name Jeffrey Lawrence Schwartz; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.